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Background: Spermatozoa are extremely vulnerable to oxidative stress caused by the unbalance between
concentrations of reactive oxygen species and antioxidant scavenging systems present inside the male reproductive
tract. In spite of a large number of clinical studies that claimed the beneficial effects of antioxidant oral
administration on sperm physiology and fertility, only a few studies were addressed to evaluate their effects on
spermatozoa in vitro. Main aims of the present study were to assess the influence of zinc, D-aspartate and coenzyme
Q10, included in the dietary supplement Genadis (Merck Serono), on human sperm motility, DNA fragmentation and
lipid peroxidation.
Methods: Semen samples, obtained from forty-four patients (23–30 years of age) were enrolled in this study,
twenty-four were normospermic and twenty patients were oligospermic. Semen samples were analysed for
sperm progressive motility and kinetics through computer assisted analysis, DNA fragmentation and lipid
peroxidation.
Results: Main results showed that in both normo and oligospermic samples, total and progressive sperm
motility is maintained by in vitro treatment with zinc, D-aspartate and coenzyme Q10, whereas a significant
decrease of these parameters occurs in parallel samples incubated in medium alone. Zinc, D-aspartate and
coenzyme Q10 also prevented the decrease of sperm kinetics but such an effect was highly significant only
in oligospermic samples. Moreover, they also protected spermatozoa by the increase of DNA fragmentation
and lipid peroxidation.
Conclusions: Zinc, D-aspartate and coenzyme Q10 exert a direct protective effect on human spermatozoa preventing
the decrease of motility and the increase of DNA fragmentation and lipid peroxidation during in vitro culture.
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Oxidative stress manifests when reactive oxygen species
(ROS), that include hydroxyl radicals, superoxide anions
and hydrogen peroxide [1-3], overwhelm the antioxidant
defence system in cells. Spermatozoa were the first cell
type showing a potential susceptibility to oxidative damage
[4]. They are particularly vulnerable to oxidative stress
caused by the imbalance between ROS and antioxidant* Correspondence: riccardo.talevi@unina.it
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reproduction in any medium, provided the orscavenging systems of the male reproductive tract. In
physiological conditions, a balance called oxidative stress
status exists between ROS production and antioxidant
scavenging system in the male reproductive tract [5]
where the principal sources of ROS are leukocytes and
abnormal spermatozoa [6,7]. However, low levels of ROS
are essential for the regulation of sperm functions such as
capacitation, acrosome reaction, and sperm-oocyte fusion
[8,9]. Spermatozoa are particularly vulnerable to oxidative
stress as they are characterized by: 1) high polyunsaturated
fatty acid content; 2) intrinsic deficiencies in intracellular
antioxidant enzymes; and 3) limited capacity of DNAtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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enzymatic and non-enzymatic antioxidant molecules (such
as vitamins C and E, folate, zinc, selenium, carnitine and
carotenoids) that act as scavengers of ROS and protect
spermatozoa. High ROS levels have been detected in the
semen samples of 25% to 40% of infertile men [10,11].
Moreover, male idiopathic infertility has been correlated
with high seminal ROS levels and low antioxidant potential
compared to healthy fertile controls [12].
ROS cause infertility by two principal mechanisms
damaging the sperm membrane via lipid peroxidation
with consequent reduction of sperm motility and ability
to fuse with the oocyte [13,14], and sperm DNA, com-
promising the paternal genomic contribution to the em-
bryo [15-18]. Several studies showed that men with high
dietary intake of antioxidants have a lower frequency of
sperm aneuploidy and improved semen quality compared
with men with low intake [19,20]. As a result, over the last
decade, several antioxidant nutraceutical formulations have
been developed and proposed as a therapy for male infer-
tility. Recently, a new nutraceutical formulation containing
zinc, D-aspartate (D-Asp) and Coenzyme Q10 (CoQ10), a
combination of antioxidants and micronutrients, has been
developed by Merck Serono.
Zinc is a cofactor for several metalloenzymes involved
in DNA transcription and protein synthesis and also has
anti-apoptotic and antioxidant properties [21]. Zinc ther-
apy in men with asthenozoospermia resulted in a signifi-
cant increase in sperm concentration, progressive motility,
sperm integrity and improved conception and pregnancy
rates [22].
D-Asp is an endogenous amino acid found in the ner-
vous and endocrine system of various animal species.
High concentrations of D-Asp have been found in Leydig
cells, in rat testis fluid, and in epididymal spermatozoa
[23-25]. Moreover, the concentration of D-Asp in seminal
plasma and in spermatozoa were significantly reduced in
oligoasthenoteratospermic patients [26].
CoQ10 is a component of the mitochondrial respira-
tory chain, playing a crucial role both in energy metabol-
ism and as liposoluble chain-breaking antioxidant for
cell membranes and lipoproteins [27,28]. CoQ10 biosyn-
thesis is markedly active in testis [29], and high levels of
its reduced form ubiquinol are present in spermatozoa
[30,31], suggesting a protective role as antioxidant. Dif-
ferent studies demonstrated decreased levels of CoQ10
and its reduced form in seminal plasma and sperm-
atozoa of infertile men with idiopathic and varicocele-
associated asthenospermia [32]. Moreover, the exogenous
administration of CoQ10 has been reported to improve
sperm motility [33].
Although several studies evaluated the influence of
seminal plasma levels or oral administration of zinc,
D-Asp or CoQ10 on semen quality [33-41], only few dataare available on their effects in vitro [34,42]. Therefore, it is
not clear whether the beneficial effects of the therapy on
sperm physiology were due to an improvement of sperm-
atogenesis or also to a direct effect on spermatozoa. Main
aims of the present study were to assess the in vitro effects
of zinc, D-Asp and CoQ10 on human sperm motility, lipid
peroxidation and DNA fragmentation.
Methods
Chemicals
Sydney IVF Gamete Buffer was from Cook Medical
(Ireland). Zinc chloride, D-aspartic acid, Coenzyme Q10,
paraformaldehyde, Triton X100, sodium citrate, Hoechst
33342, thiobarbituric acid (TBA), acetic acid, sodium
dodecyl sulphate (SDS) were from Sigma Chemical Com-
pany (Milan, Italy). In Situ Cell Death Detection Kit, Fluor-
escein was from Roche Diagnostics (Milan, Italy). Image It
Lipid Peroxidation kit was from Invitrogen (Monza, Italy).
Patients
This study was approved by our Institutional Review
Board. Semen samples were collected, following written
informed consent, from 60 patients (23–30 years of age).
Samples were analysed according to criteria of World
Health Organization (2010) [43] for concentration and per-
cent progressive motility through Sperm Class Analyzer
(SCA Microptic S.L. Barcelona, Spain), on a heated stage
at 37°C. Semen samples with total and progressive motil-
ity below the normal values (n = 16) were excluded from
the analysis to avoid confounding variables on the ef-
fect of antioxidants on motility maintenance. Twenty-four
normospermic and twenty oligospermic patients were in-
cluded in the study.
Semen samples were washed in Sydney IVF Gamete
Buffer at 650 g for 10 min and the pellets were suspended
in fresh Sydney IVF Gamete Buffer, divided into aliquots
and treated or analysed as detailed below.
Effects of single molecules on total and progressive
sperm motility
The following stock solutions were prepared: zinc chlor-
ide 10 mg/ml in ethanol, D-Asp 50 mg/ml in gamete
buffer, CoQ10 50 mg/ml in chloroform. In all experi-
ments, controls were added with the same concentration
of vehicle present in zinc, D-Asp and CoQ10 treated
samples. In a preliminary series of experiments, total
and progressive motility was assessed on sperm suspen-
sions (n = 5) treated with different concentrations of
zinc (1,10,100 μg/ml), D-Asp (5,50,500,5000 μg/ml), or
CoQ10 (4,40,400 μg/ml), for 6 h. Samples were loaded
into a Makler chamber and analysed on a heated stage at
37°C every hour and until 6 h after treatment, at a Nikon
TE 2000 inverted microscope connected to a Basler Vi-
sion Technology A312 fc camera with a positive phase
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(SCA Microptic S.L. Barcelona, Spain). For each time point
at least 400 cells were acquired and analyzed. Data showed
a significant decrease of motility in control samples at 6 h
of incubation (Figure 1). At that time, individual optimal
concentrations that prevented the decrease of total and
progressive motility compared to controls were zinc chlor-
ide 10 μg/ml (Figure 1A), D-Asp 500 μg/ml (Figure 1B),
CoQ10 40 μg/ml (Figure 1C). Therefore, all experiments
mentioned below were performed treating samples in com-










Figure 1 Effects of single molecules on total and progressive sperm m
treated with different concentrations of (A) zinc (1,10,100 μg/ml), (B) D-Asp
incubation. # Significant differences versus control at 0 h (P < 0.05). ** SignEffect of combined treatment with antioxidants on sperm
motility and kinetics
Spermatozoa of normo (n = 24) and oligospermic patients
(n = 20) were evaluated through Sperm Class Analyser for
progressive motility and kinetics, i.e. curvilinear velocity
(VCL), straight-line velocity (VSL), average path velocity
(VAP), with the following software settings: frame rates:
25 frames/s, number of frames: 10 frames/object, vel-
ocity limit for slow spermatozoa: 10 μm/s, velocity limit
for medium spermatozoa: 15 μm/s, velocity limit for rapid
spermatozoa 35 μm/s, minimal linearity 50%, straightness






otility. Total and progressive motility of sperm suspensions (n = 5)
(5,50,500,5000 μg/ml), or (C) CoQ10 (4,40,400 μg/ml), at 6 h of
ificant differences versus control at 6 h (P < 0.01).
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Experiments addressed to study the influence of zinc,
D-Asp and CoQ10 on sperm lipid peroxidation were
performed on four responsive normo and four oligospermic
samples. As no significant differences were found between
normo and oligospermic samples, findings are reported as
cumulative data.
Sperm lipid peroxidation was evaluated biochemically
through the malondialdehyde (MDA) assay and in situ
through labeling with C11-BODIPY581/591.
The MDA assay was performed through a protocol
first described by Ohkawa et al. [44]. TBA forms colored
adduct which were quantified at 532 nm. A 100 μl ali-
quot of control and treated sperm suspensions at 0 and
6 h after beginning of the treatment with zinc chloride
10 μg/ml, D-Asp 500 μg/ml, CoQ10 40 μg/ml was mixed
with 1.5 ml of 20% acetic acid (pH 3.5). Then, 0.5 ml of
8.1% SDS, 1.5 ml of 0.8% TBA and 0.9 ml of phosphate
buffer (pH 7.4) were added and the mixture was vortexed.
The reaction mixture was incubated in a boiling water
bath for 1 h. After cooling at room temperature, 5 ml
of butanol:pyrimidine mixture (15:1) was added and the
reaction mixture was centrifuged at 4000 g for 20 min.
A clear supernatant obtained after centrifugation was
used for measuring the absorbance at 532 mm against re-
agent blank. A series of known concentrations for stand-
ard of MDA (1 nM/μl) were also run simultaneously and
a standard curve was plotted. The absorbance of samples
was plotted against the standard curve and the concen-
tration of MDA was determined as nM of MDA per 106
spermatozoa.
Visualization of lipid peroxidation in situ was carried out
through labeling with C11-BODIPY581/591, a fatty acid
analogue that readily incorporates into cell membranes and
whose fluorescence irreversibly changes from red to green
upon exposure to ROS [45]. Sperm suspensions were la-
beled with 10 μM C11-BODIPY581/591 in gamete buffer for
30 min at 37°C and then washed twice through centrifuga-
tion at 650 g for 10 min and treated with either vehicle
(controls) or antioxidants for 6 h. Samples were then ana-
lyzed at 37°C at a Leica TCS SP5 confocal microscope
(Leica, Milan, Italy) fitted with an Argon (488 nm) laser.
Red emission from intact C11-BODIPY581/591 was detected
at 580–620 nm and green emission that indicated peroxida-
tion at 495–560 nm. Percentages of peroxidized spermato-
zoa was determined counting at least 200 cells per sample.
Sperm DNA fragmentation
Experiments addressed to study the influence of zinc,
D-Asp and CoQ10 on sperm DNA fragmentation were
performed on four responsive normo and four oligo-
spermic samples. As no significant differences were found
between normo and oligospermic samples, findings are
reported as cumulative data.Sperm DNA fragmentation was measured by the TUNEL
assay in control and treated samples at 0 and 6 h after treat-
ment. Different aliquots of the same semen samples were
treated with zinc, D-Asp and CoQ10, or vehicle. Samples
were then centrifuged at 400 g for 10 min, fixed in 4% para-
formaldehyde in phosphate buffered saline (PBS) for
30 min at room temperature, washed three times in PBS
through centrifugation at 400 g for 10 min, smeared on
glass slides and air dried. Samples were permeabilized in
0.1% Triton X-100 in 0.1% sodium citrate for 5 min at 4°C,
washed in PBS three times for 10 min and then incubated
in TUNEL reaction mixture according to the manufacturer
for 1 h in the dark at 37°C . At the end of incubation, slides
were washed in PBS as above, labelled with Hoechst 33342
10 μg/ml for 7 min at room temperature, washed again in
PBS, mounted and observed at a Nikon TE 2000 fluores-
cence microscope. Images were acquired using a Nikon
DS-cooled camera head DS-5Mc connected to a Nikon DS
camera control unit DS-L1 using the same exposure condi-
tions. In each procedure negative and positive controls
were prepared by omission of TdT in the reaction mixture
or by pretreatment with 1 mg/ml DNase I (Roche Diagnos-
tics) for 10 min at room temperature. At least 200 sperm-
atozoa were analysed in each sample.
Statistical analysis
The data are presented as the mean ± SD. Overall, ana-
lysis was performed by Fisher’s exact test or by the esti-
mate model of ANOVA followed by the Tukey’s honestly
significant difference test for pairwise comparisons when
overall significance was detected.
Results
Sperm progressive motility and kinetics
To understand whether zinc, D-Asp and CoQ10 affect
progressive motility, spermatozoa of normo (n = 24) and
oligospermic patients (n = 20) were treated with zinc
chloride 10 μg/ml, D-Asp 500 μg/ml, CoQ10 40 μg/ml.
Data showed that a positive response was observed in all
sperm suspensions in which the control had a significant
decrease of motility during the 6 h of analysis (75% of
patients: 18 normo and 15 oligospermic). In responsive
normospermic patients (Figure 2A) initial total motility
was 81 ± 9.6%, and progressive motility was 70 ± 10.9%.
A significant decrease of both values was observed after
6 h of incubation in medium alone (motility 46 ± 15.2%,
progressive motility 31.5 ± 13.9%; control 0 h vs control
6 h, P < 0.01). Interestingly, treatment with zinc, D-Asp
and CoQ10 prevented the drop of motility observed in par-
allel control samples (motility 70.2 ± 12%, progressive mo-
tility 54.8 ± 13.9%; 6 h, control vs treatment, P < 0.01).
In responsive oligospermic patients (Figure 2B) initial
total motility was 70.3 ± 9%, and progressive motility









Figure 2 Effects of zinc, D-Asp and CoQ10 on total and progressive sperm motility. Normospermic (n = 18) (A) and oligospermic (n = 15)
(B) sperm suspensions treated with zinc, D-Asp and CoQ10. # # Significant differences versus control at 0 h (P < 0.01); ** Significant differences
versus control at 6 h (P < 0.01).
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43.6 ± 13%, progressive motility 31.3 ± 12%; control 0 h vs
control 6 h, P < 0.01). Interestingly, treatment with zinc,
D-Asp and CoQ10 prevented the drop of motility ob-
served in parallel control samples (motility 64.6 ± 3.5%,
progressive motility 58.3 ± 3.2%; 6 h, control vs treatment,
P < 0.01).
Initial mean kinetic parameters in responsive normo-
spermic patients (Figure 3A) were: VCL 66.6 ± 11.8 μm/sec,
VSL 37 ± 9.49 μm/sec, VAP 47.1 ± 9.6 μm/sec. After 6 h of
incubation, all values decreased in control samples (VCL
55.5 ± 12.3 μm/sec, VSL 31,4 ± 11.1 μm/sec, VAP 37.9 ±
10.8 μm/sec; control 0 h vs control 6 h, not significant)
whereas they were maintained in treated parallel samples
(VCL 64.8 ± 14.8 μm/sec, VSL 39,3 ± 13.8 μm/sec, VAP
46.4 ± 13.6 μm/sec; 6 h, control vs treatment, not signifi-
cant). Although a similar trend was observed in responsiveoligospermic patients (Figure 3B), the drop of kinetics at
6 h in medium alone was highly significant (control 0 h vs
control 6 h, VCL 81.1 ± 8 vs 57.7 ± 10 μm/sec, VSL 46 ± 5
vs 35.7 ± 9.6 μm/sec, VAP 57.4 ± 5.4 vs 42.1 ± 8.4 μm/sec,
P < 0.01) and it was prevented by the treatment with zinc,
D-Asp and CoQ10 (VCL 76.6 ± 9.4 μm/sec, VSL 51,3 ±
11.9 μm/sec, VAP 58.5 ± 9.9 μm/sec; 6 h, control vs treat-
ment, P < 0.01).
Sperm lipid peroxidation and DNA fragmentation
The lipid peroxide contents, as determined by MDA
assay (Figure 4), in sperm samples at 0 h was 1,67 ± 0,47
nM MDA/106 spermatozoa. These initial values were
markedly and significantly increased after 6 h of incuba-
tion in medium alone (5,35 ± 3,48 nM MDA/106 sperm-
atozoa, control 0 h vs control 6 h, P < 0.01) whereas lipid








Figure 3 Effects of zinc, D-Asp and CoQ10 on sperm kinetics. Normospermic ( n = 18) (A) and oligospermic (n = 15) (B) sperm suspensions.
VAP, path velocity; VCL, curvilinear velocity; VSL, straight line velocity. # # Significant differences versus control at 0 h (P <0.01); ** Significant
differences versus control at 6 h (P < 0.01).
Figure 4 Effects of zinc, D-Asp and CoQ10 on sperm lipid
peroxidation. Malondialdehyde assay of normospermic (n = 4) and
oligospermic (n = 4) sperm suspensions (pooled data). # # Significant
differences versus control at 0 h (P <0.01); ** Significant differences
versus control at 6 h (P < 0.01).
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zoa; 6 h, control vs treatment, P < 0.01).
Spermatozoa were washed and labeled with the fluor-
escent lipid peroxidation reporter probe C11-BODIPY
581/591 and then treated for 6 h with zinc, D-Asp and
CoQ10 or in medium alone. At the confocal laser scan-
ning microscope, unperoxidized spermatozoa were char-
acterized by a red fluorescence localized over the whole
cell (Figure 5A) whereas peroxidized spermatozoa were
characterized by a green fluorescence mainly at the level
of the midpiece and tail but in some cases distributed
also on the sperm head plasma membrane (Figure 5E).
Most spermatozoa in the initial suspensions and after
6 h of treatment were unperoxidized (Figure 5A), whereas
in control samples at 6 h there was a decrease of spermato-
zoa with red fluorescence and a concomitant increase
of cells showing a green fluorescence (Figure 5D,E). The
Figure 5 Confocal laser scanning micrographs of sperm lipid peroxidation. Spermatozoa labeled with C11-BODIPY581/591 to visualize lipid
peroxidation. A-C, unperoxidized spermatozoa; D-F peroxidized spermatozoa. A,D, red channel; B,E, green channel; C,F, merge. Bar, 10 μm.
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of incubation was increased three times compared to the
initial sperm suspensions (21.3 ± 5.2 vs 7.3 ±5.2, P < 0.01)
whereas such an increase was prevented in treated samples
(6 h, control vs treatment, 21.3 ± 5.2 vs 8.1 ± 3.5, P < 0.01).
Experiments were addressed to evaluate the DNA frag-
mentation in the initial suspensions and after 6 h of
incubation. Data (Figure 7A) showed that the percent-
age of spermatozoa with fragmented DNA (Figure 7B)
significantly increased from 13.6 ± 1.4 in the initial sus-
pensions to 22.7 ± 3.4% after 6 h of incubation (P < 0.01),
whereas treatment with zinc, D-Asp and CoQ10 had a
protective effect on sperm DNA fragmentation (15 ±1.7%;
treatment 6 h vs control 0 h, NS; treatment 6 h vs control
6 h, P < 0.01).Figure 6 Effects of zinc, D-Asp and CoQ10 on sperm lipid
peroxidation. Sperm suspensions of normospermic (n = 4) and
oligospermic (n = 4) samples labeled with C11-BODIPY581/591
(pooled data). # # Significant differences versus control at 0 h
(P < 0.01); ** Significant differences versus control at 6 h (P < 0.01).Discussion
Reactive oxygen species are involved in several cellular
signaling mechanisms and they can interact with lipids,
proteins and DNA, leading to severe pathologic conditions.
High ROS levels are detrimental to gametes, and com-
promise their function through lipid peroxidation, proteinFigure 7 Effects of zinc, D-Asp and CoQ10 on sperm DNA
fragmentation. A) Sperm suspensions of normospermic (n = 4) and
oligospermic (n = 4) samples labeled through the TUNEL assay
(pooled data). B) Representative micrograph of spermatozoa labeled
with Hoechst (blue) and TUNEL (green). Bar, 20 μm # # Significant
differences versus control at 0 h (P < 0.01); ** Significant differences
versus control at 6 h (P < 0.01).
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atozoa physiologically produce ROS promoting sperm cap-
acitation, in some pathological conditions the semen ROS
levels exceeds the sperm antioxidant defenses and lead
to a state of oxidative stress that could impair not only
fertilization but also embryo development [18]. In vivo
studies suggested that oral administration of antioxidants
improves semen quality and pregnancy rates in subfertile
men [46,47]. However, among several studies on the ef-
fect of antioxidants on semen quality, only a few were
addressed to understand their direct action on sperm
physiology in vitro. To this end, in the present study we
evaluated the effects of zinc, D-Asp and CoQ10 on
sperm physiology in vitro. Main results demonstrated
that the in vitro treatment of human spermatozoa with
zinc, D-Asp and CoQ10 1) preserves sperm motility and
kinetics; 2) avoids sperm lipid peroxidation, and 3) DNA
fragmentation.
To our knowledge, the present work represents the
first addressing the effects of a combined in vitro treat-
ment with zinc, D-Asp and CoQ10 on human spermato-
zoa. Several studies have been carried out on the role
played by each of these molecules on spermatogenesis,
sperm quality and fertility.
Zinc concentration in seminal plasma is generally
higher than in serum and has been positively corre-
lated with sperm count and motility [21,48,49]. On the
other hand, a negative effect of high zinc levels in sem-
inal plasma or in sperm tails on sperm motility has
been reported by others [50,51]. Despite these contra-
dictory results, the role of zinc as an antioxidant is well
established. Zinc in vitro is able to inhibit both super-
oxide anion generation and SOD-like activity in sperm-
atozoa of infertile men [52].
Little is known about the role of D-Asp in human
reproduction. The concentration of D-Asp in seminal
plasma and in spermatozoa was significantly reduced
in oligoasthenoteratospermic men [26]. Moreover, DL-
Aspartic acid administration has been reported to improve
semen quality in rabbits [37].
CoQ10 has a bioenergetic and an antioxidant role
and has been suggested to be involved in male infer-
tility [53]. High levels of oxidative stress and a low
antioxidant capacity in varicocele patients has been cor-
related to an altered distribution of CoQ10 in spermato-
zoa and seminal plasma [32]. CoQ10 administration has
been reported to have a positive role in the treatment of
asthenozoospermia [33].
Our results on the in vitro effects of zinc, D Asp and
CoQ10 confirm the role played by the single molecules
on human spermatozoa and demonstrate that they are
able to protect spermatozoa from the oxidative stress
during in vitro manipulation. Analysis of sperm motility
and kinetics demonstrated that the supplementation ofculture media with the three molecules prevents the drop
of these values observed in medium alone. Such an effect
was evident in 75% of samples in which a significant de-
crease of motility and kinetics was observed at 6 hours of
incubation in medium alone. This indicate that a prelimin-
ary analysis of sperm motility dynamics on washed semen
samples could help to identify responsive patients. The lack
of response in 25% of samples analysed could be due to the
presence of a correct balance between antioxidant defenses
and ROS generation in those ejaculates.
Sperm plasma membrane plays fundamental roles dur-
ing sperm transport within the female reproductive tract,
in sperm capacitation, in sperm–egg interaction and,
finally, in fertilization. For these reasons, the plasma
membrane lipid composition of spermatozoa is different
from somatic cells for the high content of highly polyun-
saturated fatty acids. These unsaturated fatty acids confer
to the sperm membrane a great fluidity needed to partici-
pate in the membrane fusion events associated with cap-
acitation and fertilization. On the other hand this makes
spermatozoa particularly vulnerable to the attack by ROS,
and therefore more susceptible to undergo lipid peroxida-
tion [54]. Several studies examined the role of in vitro and
in vivo antioxidant supplementation in protecting sperm
from lipid peroxidation due to an imbalanced ROS produc-
tion [55-57]. In the present paper, data demonstrated that
treatment with zinc, D Asp and CoQ10 protects sperm
plasma membrane from lipid peroxidation. This protection
could be due to CoQ10 that has been previously reported
to decrease lipid peroxidation when administered in a rat
model of ischemia/reperfusion injury [41].
High levels of ROS can induce DNA damage in sperm-
atozoa in every moment of their life. This damage can be
produced during comigration of mature and immature
spermatozoa from the seminiferous tubules to the caudal
epididymis where sperm are highly packed and this would
facilitate ROS-induced DNA damage [58]. Moreover, the
process of DNA fragmentation in spermatozoa progresses
even after ejaculation. In vitro incubation of swim-up se-
lected human spermatozoa results in a progressive increase
in the percentage of DNA fragmented sperm [59].
In agreement with those studies we found that sperm
culture for 6 hours induces an increase of sperm DNA
fragmentation and, more interestingly, it is prevented by
antioxidant treatment. According to Aitken et al., [18]
sperm oxidative stress not only could impair the sperm
fertilizing ability but also its competence to sustain a cor-
rect embryo development. Moreover, DNA damage in hu-
man spermatozoa has been correlated with increased
miscarriage rates and morbidity in the offspring [59,60].
The possibility to answer these questions directly in the
human is limited by a number of ethical and methodo-
logical reasons. Studies in animal models could provide
insights into these fundamental questions.
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Overall, data here presented demonstrate that in vitro
treatment of human spermatozoa with zinc, D Asp and
CoQ10 exerts a direct protective effect on sperm motil-
ity, kinetics, lipid peroxidation and DNA fragmentation
during handling and extended culture. As semen process-
ing, handling and cryopreservation represent crucial steps
during assisted reproduction techniques, the supplementa-
tion of new sperm culture media with zinc, D Asp and
CoQ10 could be an useful tool to preserve sperm physi-
ology against damage induced by oxidative stress.
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